Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Jun 9;9(6):e24952.
doi: 10.2196/24952.

An Intervention to Improve Medication Adherence in People With Heart Disease (Text4HeartII): Randomized Controlled Trial

Ralph Maddison #  1 , Yannan Jiang  2 , Ralph Stewart  3 , Tony Scott  4 , Andrew Kerr  5 , Robyn Whittaker  6   7 , Jocelyn Benatar  3 , Anna Rolleston  8 , Paul Estabrooks  9 , Leila Dale  6
Affiliations
Randomized Controlled Trial

An Intervention to Improve Medication Adherence in People With Heart Disease (Text4HeartII): Randomized Controlled Trial

Ralph Maddison et al. JMIR Mhealth Uhealth. .

Abstract

Background: Mobile health technologies have the potential to improve the reach and delivery of interventions for promoting long-term secondary prevention of coronary heart disease.

Objective: This study aims to determine the effectiveness of an SMS text messaging intervention (Text4HeartII) for improving adherence to medication and lifestyle changes over and above usual care in people with coronary heart disease at 24 and 52 weeks.

Methods: A two-arm, parallel, randomized controlled trial was conducted in New Zealand. Participants with a recent acute coronary syndrome were randomized to receive usual cardiac services alone (control, n=153) or a 24-week SMS text message program for supporting self-management plus usual cardiac services (n=153). The primary outcome was adherence to medication at 24 weeks, defined as a medication possession ratio of 80% or more for aspirin, statin, and antihypertensive therapy. Secondary outcomes included medication possession ratio at 52 weeks, self-reported medication adherence, adherence to healthy lifestyle behaviors, and health-related quality of life at 24 and 52 weeks.

Results: Participants were predominantly male (113/306, 80.3%) and European New Zealanders (210/306, 68.6%), with a mean age of 61 years (SD 11 years). Groups were comparable at baseline. National hospitalization and pharmacy dispensing records were available for all participants; 92% (282/306, 92.1%) of participants completed a 24-week questionnaire and 95.1% (291/306) of participants completed a 52-week questionnaire. Adherence with 3 medication classes were lower in the intervention group than in the control group (87/153, 56.8% vs 105/153, 68.6%, odds ratio 0.60, 95% CI 0.38-0.96; P=.03) and 52 weeks (104/153, 67.9% vs 83/153, 54.2%; odds ratio 0.56, 95% CI 0.35-0.89; P=.01). Self-reported medication adherence scores showed the same trend at 52 weeks (mean difference 0.3; 95% CI 0.01-0.59; P=.04). Moreover, self-reported adherence to health-related behaviors was similar between groups.

Conclusions: Text4HeartII did not improve dispensed medication or adherence to a favorable lifestyle over and above usual care. This finding contrasts with previous studies and highlights that the benefits of text interventions may depend on the context in which they are used.

Trial registration: Australian New Zealand Clinical Trials Registry ACTRN12616000422426; http://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=370398.

International registered report identifier (irrid): RR2-10.1186/s13063-018-2468-z.

Keywords: cardiovascular disease; risk factors; self-management; text messaging.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
Participant flow.
See this image and copyright information in PMC

References

    1. Cardiovascular diseases (CVDs) World Health Organization. 2011. [2021-05-21]. https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-disea...
    1. Australian Institute of Health and Welfare . Cardiovascular disease, diabetes and chronic kidney disease: Australian facts: prevalence and incidence. Canberra, Australia: Australian Institute of Health and Welfare; 2014. pp. 1–100.
    1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics - 2015 update: a report from the American Heart Association. Circulation. 2015 Jan 27;131(4):29–322. doi: 10.1161/CIR.0000000000000152. - DOI - PubMed
    1. Taylor R, Kirby B. The evidence base for the cost effectiveness of cardiac rehabilitation. Heart. 1997 Jul 01;78(1):5–6. doi: 10.1136/hrt.78.1.5. http://heart.bmj.com/cgi/pmidlookup?view=long&pmid=9290390 - DOI - PMC - PubMed
    1. Riegel B, Moser DK, Buck HG, Dickson VV, Dunbar SB, Lee CS, Lennie TA, Lindenfeld J, Mitchell JE, Treat‐Jacobson DJ, Webber DE. Self‐care for the prevention and management of cardiovascular disease and stroke. J Am Heart Assoc. 2017 Sep 22;6(9):e006997. doi: 10.1161/jaha.117.006997. - DOI - PMC - PubMed

Publication types